diabetes

Top 5 neuro signs never to ignoreLet’s examine case-based examples to emphasize the top five neuro-ophthalmic disorders that should not be overlooked.
Amputation risk possible with diabetes drugs, FDA warnsBased on new data from 2 large clinical trials, FDA is warning that these blockbuster type 2 diabetes medications can cause an increased risk of leg and foot amputations.
New strategies to assess the risk of diabetes-related vision lossA colleague recently told me that eye doctors should “stay within the lines” of traditional eye care because we barely have enough time as it is to do our jobs. My response was that today more than half of our adult patients have either diabetes or prediabetes, so our job now requires we go ”outside the lines” to avoid the leading cause of preventable blindness.
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and More
Small Doses: Pharmacy News Featuring Vaccine Skeptics, an Aspirin-Cancer Link, and MoreEasy-to-swallow bits of news from around the world of pharmacy.
New FDA Warning on Canagliflozin
New FDA Warning on CanagliflozinStudies have linked type 2 diabetes drug to increased risk of foot and leg amputations.
Rising diabetes rates in children: Four things health execs should knowHere are four things MCOs should know about a new study focusing on young patients with diabetes.
Autoimmune drug pipeline: What health execs should watchNew drugs for RA, psoriasis, type 1 diabetes and Crohn’s disease—some recently approved and others coming down the pipeline—could have an impact on the industry.
Diabetes prevention programs avert, delay disease onsetDiabetes accounts for one out of every 10 American healthcare dollars spent, but new national programs are helping address this issue.
Here’s why preventive care should be a priorityA Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.
CE: Diabetes: Setting the stride to improve glycemic control
CE: Diabetes: Setting the stride to improve glycemic control